IFIH1 and dermatomyositis: The anti-MDA5 antibody is found mainly in patients with amyopathic or hypomyopathic DM, with a high risk of rapidly progressive ILD and a poor respiratory prognosis, but with a generally low or non-significant oncologic risk [23].